Join to View Full Profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Dr. Morse is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1993 - 1996
University of WashingtonResidency, Internal Medicine, 1990 - 1993
Yale School of MedicineClass of 1990
Certifications & Licensure
NC State Medical License 1996 - 2027
FL State Medical License 2012 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer Start of enrollment: 2010 Mar 01
- QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA Start of enrollment: 2010 Jul 16
Publications & Presentations
PubMed
- 2 citationsSystemic Treatment Followed by Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer: A Retrospectively Observational a...Guoliang Qiao, Xueli Bai, Xiang Li, Qi Zhang, Yiwen Chen
Annals of Surgery. 2026-08-01 - 65 citationsAdvances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians.Dimitrios Moris, Alessandro Martinino, Sarah Schiltz, Peter J Allen, Andrew Barbas
CA. 2025-05-20 - 1 citationsClinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy.Congcong Li, Dazhao Xu, Linyao Lu, Shu Peng, Haiyang Zhao
Infectious Agents and Cancer. 2025-04-09
Press Mentions
Theriva Biologics to Host Key Opinion Leader Webinar on Lead Program, VCN-01 and Advancing Unique Oncolytic Virus TherapeuticsOctober 31st, 2022- Genprex Targets Non-Small Cell Lung Cancer and Diabetes via Gene TherapyApril 6th, 2021
- Genprex Announces Formation of Clinical Advisory BoardFebruary 8th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
